Suppr超能文献

长期抗高血压治疗可抑制糖尿病肾病进展。

Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.

作者信息

Mogensen C E

出版信息

Br Med J (Clin Res Ed). 1982 Sep 11;285(6343):685-8. doi: 10.1136/bmj.285.6343.685.

Abstract

Six men aged 26-35 years with proteinuria due to insulindependent juvenile-onset diabetes were treated for moderate hypertension (mean blood pressure 162/103 mm Hg) and studied for a mean of 73 months for the effect on the progression of nephropathy. All patients were of normal weight. During a mean control period of 28 months before treatment the mean glomerular filtration rate (three or four measurements) was 86.1 ml/min and mean 24-hour urinary albumin excretion (also three or four measurements) 3.9 g (range 0.5-8.8 g).During antihypertensive treatment the mean systolic blood pressure fell to 144 mm Hg and mean diastolic pressure to 95 mm Hg. In the control period five patients had shown a mean monthly decline in glomerular filtration rate of 1.23 ml/min; with antihypertensive treatment, however, this decline fell to 0.49 ml/min (2p=0.042). In the remaining patient the glomerular filtration rate was 137 ml/min before treatment and 135 ml/min at the end of the treatment period. In all patients the mean yearly increase in albumin clearance (expressed as a percentage of the glomerular filtration rate) fell from 107% before treatment to 5% during treatment (2p=0.0099).This small study indicates that antihypertensive treatment slows the decline in renal function in diabetic nephropathy. Clinical trials beginning treatment in the incipient phase of diabetic nephropathy will define the optimal modality of treatment in this large patient population.

摘要

6名年龄在26至35岁之间、因胰岛素依赖型青少年发病糖尿病而出现蛋白尿的男性患者,接受了中度高血压(平均血压162/103毫米汞柱)治疗,并对其进行了平均73个月的研究,以观察对肾病进展的影响。所有患者体重均正常。在治疗前平均28个月的对照期内,平均肾小球滤过率(测量三或四次)为86.1毫升/分钟,平均24小时尿白蛋白排泄量(同样测量三或四次)为3.9克(范围为0.5至8.8克)。在抗高血压治疗期间,平均收缩压降至144毫米汞柱,平均舒张压降至95毫米汞柱。在对照期,5名患者的肾小球滤过率平均每月下降1.23毫升/分钟;然而,在抗高血压治疗期间,这种下降降至0.49毫升/分钟(P=0.042)。在其余患者中,治疗前肾小球滤过率为137毫升/分钟,治疗期末为135毫升/分钟。在所有患者中,白蛋白清除率的平均年增长率(以肾小球滤过率的百分比表示)从治疗前的107%降至治疗期间的5%(P=0.0099)。这项小型研究表明,抗高血压治疗可减缓糖尿病肾病患者肾功能的下降。在糖尿病肾病初期开始治疗的临床试验将确定这一庞大患者群体的最佳治疗方式。

相似文献

引用本文的文献

1
Progression and regression of kidney disease in type 1 diabetes.1型糖尿病肾病的进展与逆转
Front Nephrol. 2023 Dec 14;3:1282818. doi: 10.3389/fneph.2023.1282818. eCollection 2023.
2
Hypertension in Non-Type 2 Diabetes in Isfahan, Iran: Incidence and Risk Factors.
Int J Hypertens. 2017;2017:3132729. doi: 10.1155/2017/3132729. Epub 2017 Dec 20.

本文引用的文献

1
Genesis and evolution of diabetic nephropathy.糖尿病肾病的发生与演变
J Clin Pathol. 1981 Nov;34(11):1261-6. doi: 10.1136/jcp.34.11.1261.
2
Diabetic nephropathy: fault or destiny?糖尿病肾病:是过错还是宿命?
Diabetologia. 1981 Sep;21(3):178-83. doi: 10.1007/BF00252651.
4
A trial of metoprolol in hypertensive insulin-dependent diabetic patients.
Acta Med Scand. 1982 May;211(3):175-8. doi: 10.1111/j.0954-6820.1982.tb01923.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验